Fractyl Health

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Filter

År

Typ

Språk

Rensa

2025-12-15 23:45:00 Fractyl Health Announces Call of Tranche A Warrants Tied to August 2025 Public Offering Following Achievement of Clinical and Trading Milestones

2025-12-02 13:00:00 Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure 1,84 USD | +17,95%

2025-12-01 13:00:00 Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference 1,56 USD | -0,64%

2025-11-05 13:00:00 Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025 1,13 USD | +0,89%

2025-10-07 13:00:00 Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity 1,37 USD | -6,80%

2025-09-26 13:05:00 Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock 1,34 USD | +32,67%

2025-09-26 13:00:00 Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita® Maintained Weight Loss After GLP-1 Discontinuation 1,34 USD | +32,67%

2025-09-03 13:00:00 Fractyl Health Expands Board of Directors with Appointments of Industry Leaders to Advance Clinical Execution and Strategic Growth 0,93 USD | -4,43%

2025-08-06 22:05:00 Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference 1,01 USD | -45,99%

2025-08-06 14:30:00 Fractyl Health Announces Pricing of $20 Million Underwritten Public Offering 1,01 USD | -45,99%

2025-08-05 22:15:00 Fractyl Health Announces Proposed Public Offering 1,87 USD | +0,54%

2025-08-05 22:02:00 Fractyl Health Reports Potent and Durable Two-Year Real-World Outcomes with Revita® Showing Sustained Weight Loss and Improved Glucose Control After a Single Procedure 1,87 USD | +0,54%

2025-06-23 13:40:00 Fractyl Health Reports Positive 3-Month REVEAL-1 Cohort Data Showing Revita® Sustained Weight Loss After GLP-1 Discontinuation, Supporting its Potential as a First-in-Class Weight Maintenance Therapy 1,61 USD | -24,77%

2025-06-23 13:30:00 Fractyl Health Presents New Data at the American Diabetes Association’s 85th Scientific Sessions Demonstrating its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform Prevents Obesity and Type 2 Diabetes in Preclinical Models 1,61 USD | -24,77%

2025-06-13 13:00:00 Fractyl Health to Present New Preclinical Data from its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform at the American Diabetes Association's 85th Scientific Sessions 2,06 USD | -5,07%

2025-06-04 13:00:00 Fractyl Health and Bariendo Sign Letter of Intent to Prepare for Potential Offering of Revita® Across its Bariatric and Metabolic Endoscopy Centers Nationwide 1,97 USD | +1,03%

2025-05-19 13:00:00 Fractyl Health Advances Rejuva® Gene Therapy Platform with Submission of First Clinical Trial Application Module in Europe for RJVA-001 in Type 2 Diabetes

2025-05-17 13:15:00 Fractyl Health Unveils New Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025

2025-04-28 22:30:00 Fractyl Health to Present Compelling Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting 1,20 USD | -4,76%

2025-03-03 22:05:00 Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates 1,56 USD | 0,00%

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Fractyl Health

Vem äger bolaget?

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden